Search Results 2771-2780 of 17362 for Selective mutism

  1. Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in NMIBC - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

    About this study. A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of ...

  3. Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure - Mayo Clinic

    About this study. The primary objective of this Phase 2 study is to evaluate the efficacy and safety of a single antegrade intracoronary artery infusion of ...

  4. Sex Differences in OSA - Clinical Trials

    The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep ...

  5. Pressure-enabled Retrograde Occlusive Therapy With Embolization For Control Of Thyroid Disease (PROTECT Registry)

    Multi-center registry study to evaluate disease-related quality of life outcomes of thyroid embolization via pressure-enabled delivery (PED-TAE). Additional ...

  6. A Study Testing The Combination Of Dasatinib Or Imatinib To Chemotherapy Treatment With Blinatumomab For Children, Adolescents, And Young Adults With Philadelphia Chromosome Positive (Ph+) Or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) - Mayo Clinic

    Blinatumomab may strengthen the immune system's ability to fight cancer cells by activating the body's own immune cells to destroy the tumor. Dasatinib and ...

  7. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-159642 In Participants With Advanced Solid Tumors - Mayo Clinic

    About this study. A FIH study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of ...

  8. A Study To Assess A Change In Disease Activity And Adverse Events Of Intravenous Etentamig And Daratumumab (Etentamig+D) Compared To Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible For Transplant - Mayo Clinic

    Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) ...

  9. IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Study Of ALXN1920 In Adult Participants With Primary Membranous Nephropathy (PMN) - Mayo Clinic

    The primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease ...